Covington & Burling LLP

Covington & Burling LLP stands out for its 'truly unique expertise and experience in the topic of national and multilateral benefit-sharing for pathogens'. The team is well known for its strength in handling EU pharmaceutical regulatory issues and reimbursement procedures. Peter Bogaert is highly regarded for his extensive experience in advising on matters concerning medical devices and biotech issues; he co-heads the practice with Bart Van Vooren, who routinely appears before the CJEU and the EGC in contentious matters involving clinical trials' data.